348 related articles for article (PubMed ID: 14594546)
21. Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma.
Tong BJ; Tan J; Tajeda L; Das SK; Chapman JA; DuBois RN; Dey SK
Neoplasia; 2000; 2(6):483-90. PubMed ID: 11228540
[TBL] [Abstract][Full Text] [Related]
22. Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients.
Konturek PC; Konturek SJ; Bielanski W; Kania J; Zuchowicz M; Hartwich A; Rehfeld JF; Hahn EG
Dig Dis Sci; 2003 Oct; 48(10):2005-17. PubMed ID: 14627349
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Sheng H; Shao J; Kirkland SC; Isakson P; Coffey RJ; Morrow J; Beauchamp RD; DuBois RN
J Clin Invest; 1997 May; 99(9):2254-9. PubMed ID: 9151799
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
Warner TD; Mitchell JA
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13371-3. PubMed ID: 12374850
[No Abstract] [Full Text] [Related]
25. COX in a crystal ball: current status and future promise of prostaglandin research.
FitzGerald GA; Loll P
J Clin Invest; 2001 Jun; 107(11):1335-7. PubMed ID: 11390412
[No Abstract] [Full Text] [Related]
26. Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke W; Rie C; Grothey A; Schmoll HJ
J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
[TBL] [Abstract][Full Text] [Related]
27. Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia.
Fosslien E
Crit Rev Clin Lab Sci; 2000 Oct; 37(5):431-502. PubMed ID: 11078056
[TBL] [Abstract][Full Text] [Related]
28. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
29. The role of prostaglandin synthesis in prostate cancer.
Badawi AF
BJU Int; 2000 Mar; 85(4):451-62. PubMed ID: 10691825
[No Abstract] [Full Text] [Related]
30. Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress.
Hao CM; Redha R; Morrow J; Breyer MD
J Biol Chem; 2002 Jun; 277(24):21341-5. PubMed ID: 11927585
[TBL] [Abstract][Full Text] [Related]
31. Control of COX-2 and iNOS gene expressions by aspirin and salicylate.
Wu KK
Thromb Res; 2003 Jun; 110(5-6):273-6. PubMed ID: 14592547
[No Abstract] [Full Text] [Related]
32. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
33. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise.
Dannenberg AJ; Subbaramaiah K
Cancer Cell; 2003 Dec; 4(6):431-6. PubMed ID: 14706335
[No Abstract] [Full Text] [Related]
34. PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells.
Glinghammar B; Skogsberg J; Hamsten A; Ehrenborg E
Biochem Biophys Res Commun; 2003 Aug; 308(2):361-8. PubMed ID: 12901877
[TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
Totzke G; Schulze-Osthoff K; Jänicke RU
Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
[TBL] [Abstract][Full Text] [Related]
36. Rationale for the observed COX-2/COX-1 selectivity of celecoxib from Monte Carlo simulations.
Price ML; Jorgensen WL
Bioorg Med Chem Lett; 2001 Jun; 11(12):1541-4. PubMed ID: 11412976
[TBL] [Abstract][Full Text] [Related]
37. Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells.
Yang WL; Frucht H
Carcinogenesis; 2001 Sep; 22(9):1379-83. PubMed ID: 11532858
[TBL] [Abstract][Full Text] [Related]
38. COX-2 and cancer: a new approach to an old problem.
Bakhle YS
Br J Pharmacol; 2001 Nov; 134(6):1137-50. PubMed ID: 11704632
[No Abstract] [Full Text] [Related]
39. Celecoxib with chemotherapy in colorectal cancer.
Blanke CD
Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):17-21. PubMed ID: 12014863
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible El mice was increased after seizure.
Okada K; Yuhi T; Tsuji S; Yamashita U
Brain Res; 2001 Mar; 894(2):332-5. PubMed ID: 11251211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
